Razazi, K., Berti, E., Cecchini, J., Carteaux, G., Habibi, A., Bartolucci, P., Arrestier, R., Gendreau, S., Prost, N. D., Hulin, A., Dessap, A. M. (2025). Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome. PLoS ONE. https://doi.org/10.1371/journal.pone.0319527